We are focused on bringing innovation to the treatment of cachexia and other muscle wasting conditions with a vision to transform care for an under-served and vulnerable patient population, prolong and improve the quality of their lives, restore their dignity and ease the burden for the patient, carer and provider.
NEWS
Dec 4, 2024
Actimed Therapeutics to Support 17th Annual Conference on Sarcopenia, Cachexia, and Wasting Disorders
Nov 14, 2024
Actimed Therapeutics Announces Professor David Ebsworth to Become Executive Chairman